| Biomarker ID | 1522 |
| PMID | 25170626 |
| Year | 2014 |
| Biomarker | Oligophrenin-1 (OPHN1) |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in Prostate Cancer (Tumor/nonneoplastic prostate (T/N ratio): > 3 fold) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: Rho cell motility signaling pathway, RhoA activity regulation, Rho GTPase cycle, Signal transduction |
| Experiment | Prostate Cancer Vs Non Neoplastic Samples |
| Type of Biomarker | Diagnostic |
| Cohort | 15 Prostate tumor tissues and 9 non neoplastic tissues were choden for this analysis |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | NA |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |